Variant report

Variant	rs61171111
Chromosome Location	chr19:39622012-39622013
allele	C/T
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type
1	chr19:39615259..39630637-chr19:39640467..39653924,38	MCF-7	breast:
2	chr19:39621056..39623320-chr19:39625823..39628576,3	K562	blood:
3	chr19:39620628..39623686-chr19:39793053..39797178,3	K562	blood:
4	chr19:39621851..39624607-chr19:39667898..39670113,3	MCF-7	breast:

Variant related genes	Relation type
ENSG00000269172	Chromatin interaction
ENSG00000130669	Chromatin interaction

Extended variants
information (count: 36 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:30)

rs_ID	r²[population]
rs1077457	0.92[AMR][1000 genomes];0.86[EUR][1000 genomes]
rs1079442	0.88[AMR][1000 genomes];0.97[EUR][1000 genomes];0.81[ASN][1000 genomes]
rs11083509	0.94[AMR][1000 genomes];0.97[EUR][1000 genomes];0.81[ASN][1000 genomes]
rs11083510	0.94[AMR][1000 genomes];0.96[EUR][1000 genomes];0.81[ASN][1000 genomes]
rs12610624	0.86[AMR][1000 genomes];0.81[EUR][1000 genomes]
rs12611361	0.86[AFR][1000 genomes];0.98[AMR][1000 genomes];0.97[EUR][1000 genomes]
rs12611365	0.90[AFR][1000 genomes];0.98[AMR][1000 genomes];0.97[EUR][1000 genomes];0.81[ASN][1000 genomes]
rs12611376	0.90[AFR][1000 genomes];0.98[AMR][1000 genomes];0.97[EUR][1000 genomes];0.81[ASN][1000 genomes]
rs12984418	0.81[AFR][1000 genomes];0.86[AMR][1000 genomes];0.85[EUR][1000 genomes]
rs17722300	0.86[AMR][1000 genomes];0.90[EUR][1000 genomes]
rs17795295	0.86[AFR][1000 genomes];0.86[AMR][1000 genomes];0.90[EUR][1000 genomes]
rs2873913	0.86[AMR][1000 genomes];0.90[EUR][1000 genomes]
rs34058542	0.86[AMR][1000 genomes];0.81[EUR][1000 genomes]
rs34110379	0.94[AMR][1000 genomes];0.98[EUR][1000 genomes];0.82[ASN][1000 genomes]
rs34270590	0.81[EUR][1000 genomes]
rs34326918	0.82[AMR][1000 genomes];0.84[EUR][1000 genomes]
rs34808880	0.86[AMR][1000 genomes];0.90[EUR][1000 genomes]
rs34846983	0.90[AFR][1000 genomes];0.98[AMR][1000 genomes];0.97[EUR][1000 genomes]
rs35163943	0.80[EUR][1000 genomes]
rs35591784	0.86[AMR][1000 genomes];0.83[EUR][1000 genomes]
rs36148214	0.86[AMR][1000 genomes];0.85[EUR][1000 genomes]
rs3889485	0.86[AMR][1000 genomes];0.84[EUR][1000 genomes]
rs55748546	0.86[AMR][1000 genomes];0.90[EUR][1000 genomes]
rs67248178	0.90[AMR][1000 genomes];0.97[EUR][1000 genomes]
rs71356838	0.95[AFR][1000 genomes];1.00[AMR][1000 genomes];0.97[EUR][1000 genomes];0.82[ASN][1000 genomes]
rs71356839	0.94[AFR][1000 genomes];0.92[AMR][1000 genomes];0.94[EUR][1000 genomes]
rs71356840	0.83[EUR][1000 genomes]
rs71356841	0.86[AMR][1000 genomes];0.84[EUR][1000 genomes]
rs737450	0.86[AMR][1000 genomes];0.90[EUR][1000 genomes]
rs8107629	0.82[AMR][1000 genomes];0.89[EUR][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:6 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv458571	chr19:39533754-39628050	Weak transcription Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Bivalent Enhancer Genic enhancers Transcr. at gene 5' and 3' Strong transcription ZNF genes & repeats Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA	20 gene(s)	inside rSNPs	diseases
2	nsv579508	chr19:39533754-39628050	Enhancers Active TSS Flanking Active TSS Bivalent Enhancer Weak transcription ZNF genes & repeats Genic enhancers Flanking Bivalent TSS/Enh Strong transcription Bivalent/Poised TSS Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA	20 gene(s)	inside rSNPs	diseases
3	nsv1067028	chr19:39567228-39622846	Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Weak transcription Transcr. at gene 5' and 3' Bivalent/Poised TSS Strong transcription Genic enhancers ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA	18 gene(s)	inside rSNPs	diseases
4	nsv1060469	chr19:39567228-39624790	Enhancers Bivalent Enhancer Active TSS Weak transcription Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Genic enhancers Strong transcription ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA	19 gene(s)	inside rSNPs	diseases
5	nsv833829	chr19:39569681-39730777	Weak transcription Bivalent Enhancer Enhancers Strong transcription Flanking Active TSS Genic enhancers Flanking Bivalent TSS/Enh Active TSS ZNF genes & repeats Transcr. at gene 5' and 3' Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	24 gene(s)	inside rSNPs	diseases
6	nsv432048	chr19:39572060-39850060	Bivalent/Poised TSS Bivalent Enhancer Weak transcription Genic enhancers Flanking Bivalent TSS/Enh ZNF genes & repeats Active TSS Strong transcription Enhancers Flanking Active TSS Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	42 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:112 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr19:39617000-39622400	Weak transcription	Primary T killer memory cells from peripheral blood	blood
2	chr19:39617000-39630800	Weak transcription	Primary T cells from cord blood	blood
3	chr19:39617000-39635000	Weak transcription	Aorta	Aorta
4	chr19:39617200-39624800	Enhancers	Left Ventricle	heart
5	chr19:39617400-39659800	Weak transcription	Primary T regulatory cells fromperipheralblood	blood
6	chr19:39617600-39625600	Enhancers	Spleen	Spleen
7	chr19:39617600-39627600	Enhancers	Fetal Heart	heart
8	chr19:39617800-39622200	Weak transcription	Primary mononuclear cells fromperipheralblood	Blood
9	chr19:39617800-39622400	Enhancers	Breast Myoepithelial Primary Cells	Breast
10	chr19:39617800-39623000	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
11	chr19:39617800-39623200	Weak transcription	Primary Natural Killer cells fromperipheralblood	blood
12	chr19:39617800-39623800	Enhancers	Skeletal Muscle Female	skeletal muscle
13	chr19:39617800-39624000	Weak transcription	H9 Cell Line	embryonic stem cell
14	chr19:39617800-39624200	Enhancers	Brain Inferior Temporal Lobe	brain
15	chr19:39617800-39624600	Enhancers	Stomach Mucosa	stomach
16	chr19:39617800-39625000	Enhancers	Ovary	ovary
17	chr19:39617800-39625200	Enhancers	Pancreas	Pancrea
18	chr19:39617800-39627200	Weak transcription	Primary T cells fromperipheralblood	blood
19	chr19:39617800-39628600	Enhancers	Placenta	Placenta
20	chr19:39617800-39630200	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
21	chr19:39617800-39641600	Weak transcription	Thymus	Thymus
22	chr19:39618000-39622200	Weak transcription	HUES64 Cell Line	embryonic stem cell
23	chr19:39618000-39622400	Enhancers	Small Intestine	intestine
24	chr19:39618000-39623600	Enhancers	Brain Angular Gyrus	brain
25	chr19:39618000-39624400	Enhancers	Liver	Liver
26	chr19:39618000-39624600	Enhancers	Fetal Muscle Leg	muscle
27	chr19:39618200-39623600	Genic enhancers	Fetal Intestine Small	intestine
28	chr19:39618200-39623600	Weak transcription	Pancreatic Islets	Pancreatic Islet
29	chr19:39618200-39628400	Enhancers	Fetal Adrenal Gland	Adrenal Gland
30	chr19:39618400-39622200	Weak transcription	HUES48 Cell Line	embryonic stem cell
31	chr19:39618400-39624600	Enhancers	Fetal Muscle Trunk	muscle
32	chr19:39618400-39626800	Weak transcription	NHEK	skin
33	chr19:39618400-39646600	Weak transcription	Primary T helper cells fromperipheralblood	blood
34	chr19:39618800-39622200	Weak transcription	ES-I3 Cell Line	embryonic stem cell
35	chr19:39619600-39622400	Weak transcription	K562	blood
36	chr19:39619600-39624400	Genic enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
37	chr19:39620000-39623000	Weak transcription	Sigmoid Colon	Sigmoid Colon
38	chr19:39620000-39627200	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
39	chr19:39620000-39630000	Weak transcription	HepG2	liver
40	chr19:39620200-39625000	Enhancers	Lung	lung
41	chr19:39620400-39622200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
42	chr19:39620400-39622600	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
43	chr19:39620400-39624600	Enhancers	Esophagus	oesophagus
44	chr19:39620400-39624800	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
45	chr19:39620600-39622200	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin
46	chr19:39620600-39622800	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
47	chr19:39620600-39626800	Enhancers	Fetal Intestine Large	intestine
48	chr19:39620800-39622400	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
49	chr19:39621000-39622200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
50	chr19:39621000-39622400	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links